808 filings
Page 2 of 41
425
aw0mlns80qmy
20 Jun 23
Business combination disclosure
8:02am
8-K
higvg0
20 Jun 23
Overview and Update on Pending Merger to Advance Three Promising Clinical
8:00am
DEFA14A
p1xv0t6
16 Jun 23
Additional proxy soliciting materials
12:33pm
DEFA14A
w4er1 36vuz2rj
16 Jun 23
Additional proxy soliciting materials
8:30am
DEFA14A
b3r3hd8 jr1tuob68
6 Jun 23
Additional proxy soliciting materials
4:43pm
DEFM14A
23y41jbiv1m5 po
6 Jun 23
Proxy related to merger
4:31pm
8-K
4ua d78h7sdy
7 Apr 23
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4:06pm
S-8
gyks2kzu
28 Mar 23
Registration of securities for employees
4:26pm
425
hwsnw07i
28 Mar 23
Business combination disclosure
4:24pm
8-K
pgcxv7c
28 Mar 23
Infinity Pharmaceuticals Reports Full Year 2022 Financial Results
4:21pm
425
l6fna4b6
23 Feb 23
Business combination disclosure
5:27pm
425
nx7 ekigv
23 Feb 23
Business combination disclosure
5:26pm
8-K
7uogf6e8
23 Feb 23
Entry into a Material Definitive Agreement
5:23pm
SC 13G/A
fdoob elaq3s2
14 Feb 23
INFINITY PHARMACEUTICALS / Polar Capital ownership change
3:59pm
SC 13G/A
qxfwm2ia qft
9 Feb 23
INFINITY PHARMACEUTICALS / VANGUARD ownership change
11:22am
8-K
972kt zc25
30 Dec 22
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4:13pm
8-K
9smy6qkr5ibwk66ld6
14 Nov 22
Infinity Pharmaceuticals Reports Third Quarter 2022 Financial Results and Provides Business Update
7:12am